GST Rate Revisions and Weak US Generics Weigh on Pharma Q2 FY26 Performance

Last updated: 20 October 2025 Follow on Google News

India's pharmaceutical sector is expected to post moderate growth in the second quarter (Q2) of FY 2025-26, as the industry navigates a complex mix of domestic tax adjustments, global pricing pressures, and selective product gains. While new product launches and steady biosimilar sales offer some re

Daily Limit Reached

You have reached your daily limit of 2 Free News

Subscribe to CCI PRO for unlimited access

Why Upgrade to CCI PRO?

No Ads
WhatsApp Broadcasts
Daily E-Newsletter
Unlimited News Access

BEST VALUE

2 YEAR PLAN

3,499

(Inclusive of GST)

1 YEAR PLAN

1,999

(Inclusive of GST)

Buy CCI PRO Now

Already a PRO member? Login here for an ad-free experience.

Join CAclubindia WhatsApp Finance Community & stay updated with the latest TAX news, compliance alerts and important updates all in one place!

387 Views Comment Share GST Report

News posted by

CCI News Desk

Finance news reporter covering taxation, GST, income tax, business compliance, and economy updates. I simplify complex financial topics into easy-to-understand articles for professionals, taxpayers, and business owners on leading finance and tax platforms.

Comments